UPDATE: With Multimedia: U.S. FDA Approves ELIQUIS® (apixaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

View Full Size 

Download

• Full Size JPEG, 2000x1600, 2.1 MB
• Small JPEG, 480x384, 125.9 KB
• Preview JPEG, 144x115, 11.6 KB
• Thumbnail JPEG, 72x58, 3.5 KB